FINWIRES · TerminalLIVE
FINWIRES

RemeGen Expects to Return to Profit in H1; Hong Kong Shares Down 3%

By

RemeGen (HKG:9995, SHA:688331) expects to return to profit in the first half, estimating a net profit attributable to owners of approximately 4.70 billion yuan, according to a Hong Kong bourse filing on Wednesday.

The Chinese pharmaceutical company's Hong Kong shares fell 3% and Shanghai shares rose nearly 3% during the morning trade.

The net loss attributable to owners a year earlier was 449.6 million yuan.

Operating revenue is expected to surge 433% year on year to 5.85 billion yuan from 1.10 billion yuan.

The company attributed the upbeat forecast to the increase in sales revenue from its core products, telitacicept and disitamab vedotin. The agreement with AbbVie for the distribution of RC148 outside China is also expected to generate significantly higher technology licensing revenue.

Related Articles

Asia

Xiamen Tungsten to Avail of Up to 2.1 Billion Yuan of Wealth Management Products; Shares Rise 6%

Xiamen Tungsten (SHA:600549) will avail of wealth management products for up to 2.1 billion yuan, according to a Thursday filing with the Shanghai bourse.The funds will be sourced from idle proceeds from its cash management program, the tungsten materials supplier said in its filing.Shares rose 6% during the midday break on Thursday.

SHA:600549
Asia

Seiko Epson to Launch Up to 30 Billion Yen Share Buyback

Seiko Epson (TYO:6724) said its board agreed to launch an up to 30 billion yen buyback, repurchasing as many as 17 million common shares as part of its plan to drive growth investments and shareholder returns.The printer manufacturer said the share buyback will run from Aug. 7, 2026, through March 31, 2027, and all repurchased shares will be canceled, according to a Thursday filing on the Tokyo Stock Exchange.The buyback, to be conducted on the Tokyo Stock Exchange using the discretionary method, represents 5.31% of its outstanding shares excluding treasury stock.

TYO:6724
Asia

CPE Technology Unit to Buy Johor Land with Factory for MYR10 Million

CPE Technology's (KLSE:CPETECH) subsidiary, Champion Precision Technology, agreed to acquire a piece of freehold land with a factory in Johor, Malaysia, from Flomatic Industries, for 10 million ringgit, according to a Wednesday filing with Bursa Malaysia.The acquisition will be funded via proceeds from the company's initial public offering.The expansion is part of CPE's strategy to strengthen its manufacturing capabilities and expand production capacity.The transaction is expected to conclude by the second quarter of 2027, the filing said.

KLSE:CPETECH